Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Common Hepatic Artery as Inflow in Kidney Transplantation.

Duprey A, Chavent B, Maillard N, Mariat C, Alamartine E, Albertini JN, Favre JP, Barral X.

Am J Transplant. 2015 Jun 10. doi: 10.1111/ajt.13340. [Epub ahead of print]

PMID:
26095663
2.

Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit.

Claisse G, Delavenne X, Masson I, Maillard N, Alamartine E, Mariat C.

Clin Kidney J. 2015 Apr;8(2):199-201. doi: 10.1093/ckj/sfv001. Epub 2015 Jan 24.

3.

KDIGO Guidelines and Kidney Transplantation: Is the Cystatin-C Based Recommendation Relevant?

Masson I, Maillard N, Cavalier E, Alamartine E, Mariat C, Delanaye P.

Am J Transplant. 2015 Mar 24. doi: 10.1111/ajt.13258. [Epub ahead of print]

PMID:
25808194
4.

Serum cystatin C is a determinant of central pressure augmentation index measured by oscillometric method in renal transplant recipients.

Dinic M, Maillard N, Thibaudin D, Jannot M, Masson I, Alamartine E, Mariat C.

BMC Nephrol. 2014 Dec 11;15:196. doi: 10.1186/1471-2369-15-196.

5.

UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort.

Dinic M, Ghisdal L, Racapé J, Thibaudin L, Gatault P, Essig M, Le Meur Y, Noël C, Touchard G, Merville P, Ajarchouh Z, Mariat C, Abramowicz M, Abramowicz D, Alamartine E.

BMC Nephrol. 2014 Aug 28;15:138. doi: 10.1186/1471-2369-15-138.

6.

Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge.

Jannot M, Masson I, Alamartine E, Mariat C.

Ann Transplant. 2014 Jul 7;19:320-4. doi: 10.12659/AOT.890262.

7.

MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients.

Masson I, Flamant M, Maillard N, Rule AD, Vrtovsnik F, Peraldi MN, Thibaudin L, Cavalier E, Vidal-Petiot E, Bonneau C, Moranne O, Alamartine E, Mariat C, Delanaye P.

Transplantation. 2013 May 27;95(10):1211-7. doi: 10.1097/TP.0b013e318288caa6.

PMID:
23511243
8.

Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort.

Gagneux-Brunon A, Delanaye P, Maillard N, Fresard A, Basset T, Alamartine E, Lucht F, Pottel H, Mariat C.

AIDS. 2013 Jun 19;27(10):1573-81. doi: 10.1097/QAD.0b013e32835fac30.

PMID:
23435293
9.

Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study.

Rognant N, Alamartine E, Aldigier JC, Combe C, Vendrely B, Deteix P, Cluzel P, Juillard L, Vrtovsnik F, Maurice C, Fave S, Laville M.

BMC Nephrol. 2013 Feb 20;14:41. doi: 10.1186/1471-2369-14-41.

10.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.

J Clin Oncol. 2013 Apr 1;31(10):1302-9. doi: 10.1200/JCO.2012.43.2344. Epub 2013 Feb 19.

11.

Rate of renal graft function decline after one year is a strong predictor of all-cause mortality.

Moranne O, Maillard N, Fafin C, Thibaudin L, Alamartine E, Mariat C.

Am J Transplant. 2013 Mar;13(3):695-706. doi: 10.1111/ajt.12053. Epub 2013 Jan 11.

12.

Factors predictive of medication nonadherence after renal transplantation: a French observational study.

Couzi L, Moulin B, Morin MP, Albano L, Godin M, Barrou B, Alamartine E, Morelon E, Girardot-Seguin S, Mendes L, Misdrahi D, Cassuto E, Merville P.

Transplantation. 2013 Jan 27;95(2):326-32. doi: 10.1097/TP.0b013e318271d7c1.

PMID:
23149477
13.

GFR estimation using standardized cystatin C in kidney transplant recipients.

Masson I, Maillard N, Tack I, Thibaudin L, Dubourg L, Delanaye P, Cavalier E, Bonneau C, Kamar N, Morelon E, Moranne O, Alamartine E, Mariat C.

Am J Kidney Dis. 2013 Feb;61(2):279-84. doi: 10.1053/j.ajkd.2012.09.010. Epub 2012 Nov 8. Erratum in: Am J Kidney Dis. 2013 Aug;62(2):401.

PMID:
23141866
14.

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group.

N Engl J Med. 2012 Jul 26;367(4):329-39. doi: 10.1056/NEJMoa1204166.

15.

Mycophenolate sodium dosing in combination with tacrolimus: pharmacokinetic evaluation of a novel regimen in de novo tacrolimus-treated kidney transplant patients.

Pons B, Delavenne X, Mehdi M, Maillard N, Sauron C, Berthoux F, Alamartine E, Basset T, Mariat C.

Clin Nephrol. 2012 Jun;77(6):425-31.

PMID:
22595383
16.

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.

Albano L, Alamartine E, Toupance O, Moulin B, Merville P, Rerolle JP, Tetaz R, Moal MC, Kamar N, Legendre C, Quéré S, Di Giambattista F, Terpereau A, Dantal J.

Ann Transplant. 2012 Jan-Mar;17(1):58-67.

PMID:
22466910
17.

Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.

Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, Velten M, Moulin B; French Transplant Centers.

Am J Transplant. 2012 Mar;12(3):682-93. doi: 10.1111/j.1600-6143.2011.03896.x. Epub 2012 Jan 6.

18.

Comparison of acid and enzymatic methods for inulin dosage: analytical performances and impact on glomerular filtration rate evaluation.

Delanaye P, Thibaudin L, Souvignet M, Maillard N, Alamartine E, Rozet E, Cavalier E, Mariat C.

Clin Chim Acta. 2012 Mar 22;413(5-6):556-60. doi: 10.1016/j.cca.2011.11.024. Epub 2011 Dec 1.

PMID:
22155341
19.

The use of the Oxford classification of IgA nephropathy to predict renal survival.

Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2384-8. doi: 10.2215/CJN.01170211. Epub 2011 Sep 1.

20.

Impact of mycophenolic acid and tacrolimus on Th17-related immune response.

Abadja F, Atemkeng S, Alamartine E, Berthoux F, Mariat C.

Transplantation. 2011 Aug 27;92(4):396-403. doi: 10.1097/TP.0b013e3182247b5f.

PMID:
21818055
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk